These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 26216454)
1. Differential capacity of human interleukin-4 and interferon-α monocyte-derived dendritic cells for cross-presentation of free versus cell-associated antigen. Ruben JM; Bontkes HJ; Westers TM; Hooijberg E; Ossenkoppele GJ; de Gruijl TD; van de Loosdrecht AA Cancer Immunol Immunother; 2015 Nov; 64(11):1419-27. PubMed ID: 26216454 [TBL] [Abstract][Full Text] [Related]
2. Apoptotic blebs from leukemic cells as a preferred source of tumor-associated antigen for dendritic cell-based vaccines. Ruben JM; van den Ancker W; Bontkes HJ; Westers TM; Hooijberg E; Ossenkoppele GJ; de Gruijl TD; van de Loosdrecht AA Cancer Immunol Immunother; 2014 Apr; 63(4):335-45. PubMed ID: 24384837 [TBL] [Abstract][Full Text] [Related]
3. Ruben JM; Bontkes HJ; Westers TM; Hooijberg E; Ossenkoppele GJ; van de Loosdrecht AA; de Gruijl TD Oncoimmunology; 2014; 3(7):e946360. PubMed ID: 25610730 [TBL] [Abstract][Full Text] [Related]
4. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity. Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810 [TBL] [Abstract][Full Text] [Related]
5. Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes. von Euw EM; Barrio MM; Furman D; Bianchini M; Levy EM; Yee C; Li Y; Wainstok R; Mordoh J J Transl Med; 2007 Apr; 5():19. PubMed ID: 17448240 [TBL] [Abstract][Full Text] [Related]
6. Targeting interferon-alpha to dendritic cells enhances a CD8 Graham JP; Authie P; Karolina Palucka A; Zurawski G Vaccine; 2017 Aug; 35(35 Pt B):4532-4539. PubMed ID: 28743486 [TBL] [Abstract][Full Text] [Related]
7. IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells. Luft T; Luetjens P; Hochrein H; Toy T; Masterman KA; Rizkalla M; Maliszewski C; Shortman K; Cebon J; Maraskovsky E Int Immunol; 2002 Apr; 14(4):367-80. PubMed ID: 11934873 [TBL] [Abstract][Full Text] [Related]
9. Targeting Toll-like receptor 7/8 enhances uptake of apoptotic leukemic cells by monocyte-derived dendritic cells but interferes with subsequent cytokine-induced maturation. van den Ancker W; van Luijn MM; Ruben JM; Westers TM; Bontkes HJ; Ossenkoppele GJ; de Gruijl TD; van de Loosdrecht AA Cancer Immunol Immunother; 2011 Jan; 60(1):37-47. PubMed ID: 20859626 [TBL] [Abstract][Full Text] [Related]
14. Apoptotic body-loaded dendritic cells efficiently cross-prime cytotoxic T lymphocytes specific for NA17-A antigen but not for Melan-A/MART-1 antigen. Labarrière N; Bretaudeau L; Gervois N; Bodinier M; Bougras G; Diez E; Lang F; Gregoire M; Jotereau F Int J Cancer; 2002 Sep; 101(3):280-6. PubMed ID: 12209980 [TBL] [Abstract][Full Text] [Related]
15. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate. Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226 [TBL] [Abstract][Full Text] [Related]
16. Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins. Yang DH; Kim MH; Lee YK; Hong CY; Lee HJ; Nguyen-Pham TN; Bae SY; Ahn JS; Kim YK; Chung IJ; Kim HJ; Kalinski P; Lee JJ Ann Hematol; 2011 Dec; 90(12):1419-26. PubMed ID: 21465188 [TBL] [Abstract][Full Text] [Related]
17. IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL. Dubsky P; Saito H; Leogier M; Dantin C; Connolly JE; Banchereau J; Palucka AK Eur J Immunol; 2007 Jun; 37(6):1678-90. PubMed ID: 17492620 [TBL] [Abstract][Full Text] [Related]
18. Optimizing the exogenous antigen loading of monocyte-derived dendritic cells. Dieckmann D; Schultz ES; Ring B; Chames P; Held G; Hoogenboom HR; Schuler G Int Immunol; 2005 May; 17(5):621-35. PubMed ID: 15824067 [TBL] [Abstract][Full Text] [Related]
19. Peptide-loaded Langerhans cells, despite increased IL15 secretion and T-cell activation in vitro, elicit antitumor T-cell responses comparable to peptide-loaded monocyte-derived dendritic cells in vivo. Romano E; Rossi M; Ratzinger G; de Cos MA; Chung DJ; Panageas KS; Wolchok JD; Houghton AN; Chapman PB; Heller G; Yuan J; Young JW Clin Cancer Res; 2011 Apr; 17(7):1984-97. PubMed ID: 21355077 [TBL] [Abstract][Full Text] [Related]
20. Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors. Di Pucchio T; Pilla L; Capone I; Ferrantini M; Montefiore E; Urbani F; Patuzzo R; Pennacchioli E; Santinami M; Cova A; Sovena G; Arienti F; Lombardo C; Lombardi A; Caporaso P; D'Atri S; Marchetti P; Bonmassar E; Parmiani G; Belardelli F; Rivoltini L Cancer Res; 2006 May; 66(9):4943-51. PubMed ID: 16651452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]